Drug-Drug Interaction Study With Rifampin

A Study of the Effect of Concomitant Administration of Rifampin on the Pharmacokinetics of BMS-708163 in Healthy Subjects

The purpose of the study is to determine if the concomitant administration of rifampin with BMS-708163 will affect the Pharmacokinetics of BMS-708163 and to assess safety and tolerability of co-administration BMS-708163 and rifampin

Inclusion Criteria:

• Healthy male and postmenopausal female subjects, 18-55 yrs old inclusive

Exclusion Criteria:

• Women of childbearing potential
• Tuberculosis